Markets › United States › NAS › CLOV

Clover Health Investments Corp

NAS:CLOVHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$4.59−2.96%LiveIn session · ≈ AED 16.86 · Market cap $2.44B · Next earnings Wed 4 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	12.3%	−5.4%	9.4%	20.3%	26.6%	18.5%	—	—
Operating margin	−13.8%	−43.3%	−26.1%	−16.3%	−3.3%	−4.4%	−4.4%	+0.0 pts
Net margin	−20.3%	−39.9%	−31.0%	−16.9%	−3.1%	−4.4%	−4.4%	+0.0 pts
EBITDA margin	−11.7%	−38.7%	−23.0%	−16.5%	−3.3%	−4.4%	—	—
Return on equity	22.1%	−109.8%	−95.1%	−74.5%	−12.6%	−27.7%	−27.7%	+0.0 pts
Return on assets	−51.0%	−61.8%	−42.0%	−37.4%	−7.4%	−15.8%	−15.8%	+0.0 pts
Return on capital employed	−90.0%	−110.2%	−76.0%	−66.3%	−12.5%	−25.7%	—	—
Debt / equity	−0.2×	0.1×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	51.8%	2.9%	0.7%	0.8%	0.0%	0.0%	—	—
Interest coverage	−1.6×	−37.7×	−210.3×	−29,332.7×	0.0×	0.0×	—	—
Current ratio	1.2×	2.0×	1.4×	1.6×	1.6×	1.5×	1.5×	+0.0%
Quick ratio	1.2×	2.0×	1.4×	1.6×	1.6×	1.5×	—	—
Cash ratio	0.6×	0.8×	0.2×	0.4×	0.9×	0.4×	0.4×	+0.0%
Asset turnover	2.5×	1.5×	1.4×	2.2×	2.4×	3.6×	—	—
Receivables turnover	7.9×	13.5×	6.5×	14.6×	14.8×	12.1×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—